Skip to content

Drug interactions

Canakinumab + Mycophenolate mofetil

Severity: Moderate

Canakinumab and Mycophenolate mofetil: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Canakinumab blocks interleukin-1 beta and is associated with a higher risk of serious infection. Adding mycophenolate further suppresses immune defenses.

What this interaction means in plain words

Canakinumab and Mycophenolate mofetil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Canakinumab belongs to Miscellaneous; Mycophenolate mofetil belongs to Miscellaneous.

Evidence level: Low

Why it happens

Additive immunosuppression via IL-1 beta blockade and inhibition of lymphocyte proliferation.

What to do

Screen for latent infections beforehand and monitor for signs of infection during combined therapy; stop canakinumab if a serious infection develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Canakinumab and Mycophenolate mofetil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Canakinumab with Mycophenolate mofetil?

MediHelp rates the interaction as moderate. Canakinumab and Mycophenolate mofetil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Canakinumab blocks interleukin-1 beta and is associated with a higher risk of serious infection. Adding mycophenolate further suppresses immune defenses.

How serious is the interaction between Canakinumab and Mycophenolate mofetil?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Screen for latent infections beforehand and monitor for signs of infection during combined therapy; stop canakinumab if a serious infection develops.

What other medicines interact with Mycophenolate mofetil?

MediHelp also lists interactions of Mycophenolate mofetil with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal. The full list is on the Mycophenolate mofetil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in